Jianqing Zhu

Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial

Tingyan Shi, Jianqing Zhu, Yanling Feng et al. · The Lancet Oncology · 2021 · 227 citations

Medicine, Gynecology, Oncology +16

Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆

Xiaohua Wu, Jianqing Zhu, Rutie Yin et al. · Annals of Oncology · 2021 · 206 citations

Medicine, Oncology, Pharmacology +15

Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer

Ning Li, Jianqing Zhu, Rutie Yin et al. · JAMA Oncology · 2023 · 159 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions

Amer Karam, Jonathan A. Ledermann, Jae‐Weon Kim et al. · Annals of Oncology · 2017 · 153 citations · Full text

Medicine, Gynecology, Oncology +16

Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial

Ning Li, Youzhong Zhang, Jing Wang et al. · Journal of Clinical Oncology · 2022 · 73 citations

Medicine, Oncology, Pharmacology +15